September 2023

04 Sep

2023-09-04 · 17:00

Bayer's Expert Mondays - Knowledge Sharing for EMEA Innovators - Spotlight on the Public/EU Grant Landscape

digital

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

more…

18 Sep

2023-09-18 · 17:00

Bayer's Expert Mondays - Knowledge Sharing for EMEA Innovators - Your Roadmap through the EU Regulatory Jungle

digital

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

more…

25 Sep

2023-09-25 · 17:00

Bayer's Expert Mondays - Knowledge Sharing for EMEA Innovators - Venture Capital, Investment Banks: Strategic Financial Investors like Big Pharma, what are they looking for?

digital

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

more…

28 Sep

2023-09-28

Life Science Investors´Day Heidelberg

Heidelberg

The Life Science Investors’ Day facilitates a continuous exchange between investors and founders. Recognizing opportunities early and jointly realizing potential. 2023 will again bring together life science investors, founding projects and startups from all over the world. In one of the most important medical locations in Europe, the Greater Heidelberg Region. We would love you to be part of it right from the start!

more…

29 Sep

2023-09-29

BioRN Annual Conference “Next Generation Cell and Gene Therapies”

Heidelberg

After many decades of effort, the future of gene and cell therapies is incredibly promising. While these technologies were initially developed in the context of treating rare diseases caused by a single faulty gene, a variety of gene and cell-based therapies for both rare and common diseases are currently in development.

more…